Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:12 PM
Ignite Modification Date:
2025-12-24 @ 10:12 PM
NCT ID:
NCT01197235
Eligibility Criteria:
Inclusion Criteria:
* age over 18 yr
* estimated glomerular filtration rate (GFR) \< 60 ml/min/1.73m2
Exclusion Criteria:
* Chronic renal replacement therapy (hemodialysis, peritoneal dialysis, continuous renal replacement therapy)
* Pregnancy or lactation
* Use of contrast agent within 1 week
* Emergent CAG or PCI
* Not recovered from AKI(acute kidney injury)
* Use of nephrotoxic drugs within 48 hr
* Cardiogenic shock (SBP(systolic blood pressure) \< 90 mmHg) or pulmonary edema
* Uncontrolled hypertension (SBP ≥ 200 mmHg or DBP(diastolic blood pressure) ≥ 130 mmHg)
* History of hypersensitivity to contrast agent
* Known allergy or hypersensitivity to EPO(erythropoietin)
* Use of EPO within 1 month
* Anemia (hemoglobin \< 9 g/dL)
* Ventilatory care
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01197235
Study Brief:
Protocol Section:
NCT01197235